Noopept dosage and evidence
Written by Aaron CuhaReviewed Sep 2026
The short answer
Noopept is a memory drug approved in Russia, built from a two amino acid piece. It is studied for mild memory problems and protecting the brain.
Evidence grade for Noopept: Limited. The rule: people have taken it in a published study, but fewer than 100 of them. The sum on this page: 1 completed trial, none stating how many people. A grade counts how much has been done to people, not whether it works.
- People given it
- 0
- Human studies
- 1
- Found nothing
- 0
Dose
No human dose established
Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose.
1 completed trial, 0 people given it
5 effects reported, 4 unwanted, 1 wanted, by people using it, not a trial
Goal pages: Brain, memory and mood
In plain English
In plain English, from Aaron
This is how I would explain it to a friend. The evidence, with the numbers, is further down the page.
Noopept is a small memory drug sold in Russia. It is built from a piece of two amino acids, so it gets lumped in with peptides. It is not approved in the US. People buy it online as a brain booster.
What people take it for
- Sharper focus and memory.
- Less social anxiety.
- Easier talking and finding words.
What studies in people showed
There is no good study in people. In one open Russian study, people with mild memory problems took it, and everyone knew it. Their problems came after a head injury or from poor blood flow to the brain. Their brain wave readings shifted. Nobody measured memory, focus or daily life. In rats, it raised two brain growth signals, and that did not fade over 28 days.
What people report
Reports, not study results
The good
- Some people describe less social anxiety and easier talking.
The bad
- Headache is the most common complaint. It often shows up on a later dose, not the first one.
- Many people feel nothing at all, even after working up the dose.
- Some say it calms them at first, then anxiety gets worse and sleep breaks up.
- Vivid dreams and light sensitivity, even in people who notice nothing else.
Where these come from: Nootropic forum threads summarised on this page, mostly LongeCity and Bluelight. These are user reports, not a study.
My bottom line
There is no real human study here, just brain wave readings and forum logs. Plenty of people feel nothing, and headaches are common. In my opinion, fix sleep and training first.
An opinion, not a finding. I am a coach, not a doctor.
What it has been measured to do
What people using it report
Real people telling you what happened to them. Nobody checked it, and the people who post are not a fair sample, so it cannot prove anything works. It is still the best guide on this page to what people actually do with Noopept, what they expect, and what goes wrong. The full account, including the negative reports, is below.
Nothing indexed yet
The 3 citations on this page do not report a result for any of the 36 goals indexed here. Most of what sits here is something else: a listing of a planned study, a study of how the body handles the drug, a safety report or a government record. None of those tests whether it works.
Show full evidence
What is Noopept?
Noopept is a memory drug approved in Russia, built from a two amino acid piece. It is studied for mild memory problems and protecting the brain.
Noopept is a small lab-made compound built from a two amino acid piece that includes proline. That is why it gets grouped with peptide brain boosters, even though it is a small chemical. It is approved in Russia, but not by the FDA.
The evidence in people is thin, and there was no dummy group. In an open Russian study of people with mild memory problems, it shifted brain wave readings in the way brain boosters usually do. Nobody measured memory itself.
Russian drug research describes it as working at doses about 1,000 times lower than piracetam, working by mouth, and helping memory, anxiety and brain protection. In rats, one dose and 28 days of dosing both raised NGF and BDNF, two brain growth signals, in the memory center, and the effect did not fade.
How does Noopept work?
It raises BDNF and NGF, two growth signals for brain cells, and changes signaling by glutamate, a chemical messenger. That is thought to help memory and protect the brain.
What do people who took Noopept report?
This is what real people say happened to them, good and bad. Nobody measured it. A report cannot tell a real effect from the lift people get just from expecting it to work, from a diet or training change made at the same time, or from what was really in the vial. We still put it near the top. It is the next best thing to a study in people: what happens when real people use it, including what goes wrong.
- Headache is the side effect reported most, and a specific and repeated observation is that it tends not to appear on the first dose but on a later one. A survey run within one of these communities found a large majority of participants attributing at least one headache to it.
- Reports of nothing happening are common and are not a minority position. Accounts exist of people working up through the usual range and feeling nothing, and of at least one person taking an order of magnitude more than the usual amount by two routes at once and still reporting no positive effect.
- Doses described cluster in the range of roughly 10 to 30 mg, swallowed or taken under the tongue, and under the tongue is commonly claimed to be stronger.
- The effects people who do report something describe are reduced social anxiety and easier verbal fluency, and a recurring complication is rebound: an initial calming effect followed by worse anxiety and disrupted sleep on continued use.
- Vivid dreams and light sensitivity are reported by people who otherwise report nothing, which is a distinctive pattern here.
- Pairing with a choline source is standard advice and is offered as the fix for the headaches, alongside taking it once in the morning rather than repeatedly through the day. Whether any of it is just expectation is argued openly inside these forums, and at least one long write-up exists making that case.
Sources: Brain Health, Mental Health and Nootropic Stacks threads on LongeCity, and a long-form discussion on Bluelight, reached through site-restricted search extracts of the threads because LongeCity would not load from this environment, September 2026. Nothing above is attributed to any specific post and no post is reproduced.
The evidence, in charts
Fig. 1a · how many people
1study in people cited, but none says how many people took part
number of people not stated
We do not draw a total, because none of the studies in people on this page gives one. Read the sources below for what each study measured.
We read the number of people from the source lines on this page. Where a line gives no number, we count nothing for it. We do not guess.
Fig. 1b · evidence mix
1 of 3 sources here is a study in people. The rest are not.
- Study in people · done in people133%
- Animal study · done in animals133%
- Review of studies · sums up other studies133%
Counted from the list of sources on this page. It counts only what we cite, so there may be more studies out there. A review counts once, however many studies it sums up.
Fig. 2 · evidence over time
Sources here come from just two years, 2002 and 2008.
Too few different years on this page to draw a timeline. The newest source on file is from 2008, more than five years ago. Research on it may have gone quiet.
Fig. 3 · legal status at a glance
US
Not approved
UK
Not approved
AU
Not approved
CA
Not approved
Not approved in any of the four countries shown. This is what the law says, not a verdict on the science. See Legal status below for the full text and any notes.
Fig. 4 · how much does what
Nobody has tested different amounts in people
This chart would show how the effect changes as the amount goes up. For this compound, nobody has measured that in people. So we leave it empty. We will not borrow an animal chart and pretend it works the same in people.
Fig. 5 · what the molecule is
- Kind of compound
- Small molecule
- Molecule weight
- 318.4 Da
- Half-life
- Stated in words, not a numbersee the exact wording below
- Chain length
- None on file
No amino acid sequence is on file for Noopept, which is expected: a small molecule is not built from amino acids.
The studies we cite
- Study in people2008Clinical and electroencephalographic characteristic of noopept in patients with mild cognitive impairment of posttraumatic and vascular origin
This is not evidence that noopept helps anybody think better. Russian researchers gave it to patients with mild memory problems after head injury or from poor blood flow to the brain, and recorded their brain waves. The traces shifted in the direction other stimulant type compounds produce. Everybody knew who was getting the drug and everybody got it, so there is nothing to compare against. Brain waves are not memory, attention or daily function, none of which were measured here.
Open Russian clinical study: EEG changes typical of nootropic and anxiolytic action, most evident in cerebrovascular patients; not placebo-controlled.
- Review of studies2002The original novel nootropic and neuroprotective agent noopept
A Russian drug review. It says noopept works at doses about 1,000 times lower than piracetam, works by mouth, and helps memory, anxiety and brain protection.
Russian pharmacology review: noopept is active at doses about 1,000-fold lower than piracetam, with memory, anxiolytic and neuroprotective effects, and is orally active.
- Animal study2008Noopept stimulates the expression of NGF and BDNF in rat hippocampus
In rats, one dose and 28 days of noopept both raised two brain growth signals, NGF and BDNF, in the memory center. The effect did not fade with repeated dosing.
Acute and 28-day noopept increased hippocampal NGF and BDNF mRNA in rats without tolerance.
Where to buy Noopept
2 sellers list Noopept in our latest read. They are ranked by trust score, then by archive rating, then by certificate tier, then by the lowest price per milligram. Archive evidence is counted before source-backed. Each path is out of 4, and the two are not added. A higher price does not raise the score. The letter is the certificate chip. 0 of them have a published certificate that names Noopept.
Some seller links may pay this site when you buy through them. A payment never changes a seller's tier or rank, and no seller has a say in any page.
| Seller | Trust score | Vial sizes | From, per mg | Certificate for Noopept | Seller link |
|---|---|---|---|---|---|
| Sigma Compounds | 49 WeakSource-backed 3 of 4. Archive evidence 1 of 4.B | 10 mg | $6.70 | None found for Noopept | View |
| Vandl Labs | 28 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 20 mg | $2.00 | None found for Noopept | View |
- LC Lab-confirmed: the issuing laboratory echoed this certificate back
- A Current certificate, independent laboratory named, laboratory not yet checked
- B Certificate published, but no laboratory link, older than a year, or the laboratory did not recognise the published lookup
- C No certificate could be read
Every listing and vial size for Noopept · How the trust score is counted
Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.
Common questions
Has Noopept been tested in people?
Yes. 0 people given it across 1 completed trial cited here, 0 of which found nothing. Noopept is a memory drug approved in Russia, built from a two amino acid piece. It is studied for mild memory problems and protecting the brain.
What is the Noopept dosage?
No human dose established. Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose. 1 completed trial, 0 people given it
Is Noopept FDA-approved?
Not FDA-approved (approved in Russia)
Is Noopept a peptide?
It is built from two amino acids, as a proline-containing dipeptide ester. That is why it often gets grouped with peptide brain boosters, even though it is a small lab-made chemical.